Clinical Trial Update: Mosunetuzumab for CLL MRD Clearance [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for mosunetuzumab in chronic lymphocytic leukemia focusing on measurable residual disease clearance in Phase 1/2 studies. The trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Mosunetuzumab (mosunetuzumab)

Snippet

Sponsor: Inhye Ahn | Conditions: Leukemia, Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: RECRUITING